None of the thymic carcinomas showed loss of either marker except for one adenocarcinoma in which tumor cells showed loss of expression of BAP1 and a subset of tumor cells also showed loss of expression of mTAP. This evidence concerns the gene BAP1 and adenocarcinoma.